2023 World Baseball Classic Begins, Taiwan Excellence Supports
The World Baseball Classic (WBC) is returning to Taiwan, after a ten-year hiatus, for the qualifying rounds. The tournament will feature teams from Taiwan, the Netherlands, Cuba, Italy, and Panama, who will showcase their skills starting on March 8th. As the host country for the A-group preliminaries, Taiwan extends a warm welcome to the players through enthusiastic fans, fascinating cuisine, and the opportunity to experience the latest Taiwan Excellence awarded technology and lifestyle products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230311005004/en/
The WBC was postponed for two years due to the impact of COVID-19. With hygiene and safety being top priorities, Major League Baseball (MLB) has adopted stringent standards for the event. The Taiwanese organizers have prepared the world's first indoor wireless rapid antibacterial machine, the AQUECARE T1 Plus sanitizer. This innovative solution has received the Taiwan Excellence Award and will play a vital role in maintaining environmental hygiene throughout the tournament.
Because long-haul flights can cause fatigue among players, posing them a significant challenge, the organizers have provided the world's first AURAI intelligent eye massager in order to facilitate more rapid recovery. This device helps to alleviate eye fatigue, improves sleep quality, and will recharge energy levels for the players. They will also be able to use AROMASE all-in-one purifying gel which contains three different types of herbal extracts. This gel is effective in purifying the body and mind after each training session and competition. Furthermore, we prioritize environmental sustainability, and have prepared O’right toothpaste, a revolutionary toothpaste made from sustainable tree powder as a grinding agent. This toothpaste is certified by USDA Biobased.
Taiwan is well-known as a technology island, and its consumer electronics and ICT products have gained recognition from consumers worldwide. So, the organizers are providing the players with another Taiwan Excellence awarded product, the PX 4K HDR Wireless Presentation Receiver. This product supports 4K HDR wireless transmission and provides a convenient 4K wireless projection function from mobile phones and laptops to televisions, enabling players to relax and enjoy different forms of entertainment when away from the intensity of competition.
As a souvenir for players from around the world, the Qubii auto-backup device has been chosen. This is a hand-sized device that automatically backs up photos, videos, contacts, and other content while your phone is charging. This device allows players to easily back up precious game data and memories when they run out of phone storage.
Taiwan is making every effort to provide a comfortable and safe environment with the very best professional equipment, in the hopes that the teams will enjoy their stay in Taiwan and maximize their performance in the WBC. Taiwan Excellence, a globally recognized symbol of product quality and innovative design, plays an important role in this commitment. Taiwan Excellence will continue to discover and introduce more high-quality Taiwanese products, featuring innovative breakthroughs to the world, enriching the lives of people everywhere.
For more information, please visit our website https://www.taiwanexcellence.org/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230311005004/en/
Brain Lee, TAITRA
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001 To San Fu Biotech in Major Asian Countries1.4.2023 19:18:00 EEST | Press release
REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu Chemical Co., Ltd. (4755.TW) have entered a licensing agreement to develop and commercialize RGI-2001 for the prophylaxis of acute Graft-versus-host disease (aGvHD) in major Asian countries. RGI-2001, with the novel mechanism to improve existing treatments, is a potentially first-in-class small molecule drug candidate targeted for preventing aGvHD, a life-threatening complication resulting from allogeneic hematopoietic stem cell transplantation (HSCT). GvHD is a systemic disorder that occurs when the graft's immune cells recognize the host as foreign and attack the recipient’s body cells or organs, and leads to skin rash, liver problems, abdominal pain or cramps, diarrhea, and increased risk for infections. Patients undergoing allogeneic HSCT have a high-risk of developing aGVHD associated with significant morb
AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2023)31.3.2023 19:00:00 EEST | Press release
AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001. AR1001 is a potent PDE5 inhibitor with preliminary efficacy in cognition, and preclinical effects on neuron apoptosis inhibition, promotion of neurogenesis, increase in neuroplasticity, and stimulation of autophagy to remove toxic proteins. The phase 2 study was a double-blind, randomized, placebo-controlled, multi-center trial to evaluate the safety and preliminary efficacy of AR1001 over 26 and 52 weeks of treatment in patients with mild to moderate Alzheimer’s disease. The trial enrolled 210 patients at 21 research centers in the United States. Plasma collected from patients at baseline, week 26 and week 52 was analyzed by Quantarix using the Simoa HD-X analyzer. Meaningful, statistically significant changes were found over 52 weeks of treatm
KANEKA: “Development of Polymer Synthesis Technology by Microorganisms using CO2 as Direct Raw Material” selected as a NEDO Green Innovation Fund Project”31.3.2023 17:09:00 EEST | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd (Headquarters: Kobe-city, Hyogo; President: Mikio Tanji; hereinafter "Bacchus"), JGC Holdings Corporation (Headquarters: Yokohama-city Kanagawa; Chairman and CEO: Masayuki Sato; hereinafter "JGC HD"), and Shimadzu Corporation (Headquarters: Kyoto-city, Kyoto; President: Yasunori Yamamoto; hereinafter "Shimadzu") have announced that the proposal of a joint project, “Development of Polymer Synthesis Technology by microorganisms using CO2 as direct raw material (hereinafter referred to as ‘the Project’)” had been selected by the "Green Innovation Fund Project*1 / Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw Material” as a planned implementation sponsored by the New Energy and Industrial Technology Development Organization (NEDO). This press release features multimedia. View the full release here: https://www.busine
Allianz Appoints Leadership for Allianz Commercial Key Markets31.3.2023 16:11:00 EEST | Press release
As part of the implementation of its ‘Integrated Commercial’ strategy to better serve the full Commercial segment, Allianz Group today announced the leadership for four of its largest Property and Casualty Commercial insurance markets: Australia, France, Germany and the United Kingdom. In each country, the appointed single Commercial lead will represent the integrated Allianz Commercial business and bring to the market Allianz’s full set of solutions for specialty clients, large corporates, and mid-sized companies, simplifying and enhancing the experience of clients and distribution partners. “The appointment of the regional leaders in our core Allianz Commercial markets is an important, concrete step toward realizing our new integrated model, which brings together our Mid Corporate and Large Corporate insurance business for the benefit of our clients and distribution partners,” said Chris Townsend, Member of the Allianz SE Board of Management. Townsend added, “As one face to the marke
Huawei Releases 2022 Annual Report: Steady Operations, Sustainable Survival and Development31.3.2023 12:59:00 EEST | Press release
Huawei released its 2022 Annual Report today. The company reports steady operations throughout 2022, having generated CNY642.3 billion in revenue and CNY35.6 billion in net profits. Huawei continues to strengthen investment in R&D, with an annual expenditure of CNY161.5 billion in 2022, representing 25.1% of the company's annual revenue and bringing its total R&D expenditure over the past 10 years to more than CNY977.3 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230331005166/en/ (Photo: Huawei) "In 2022, a challenging external environment and non-market factors continued to take a toll on Huawei's operations", said Eric Xu, Huawei's Rotating Chairman, at the company's annual report press conference. "In the midst of this storm, we kept racing ahead, doing everything in our power to maintain business continuity and serve our customers. We also went to great lengths to grow the harvest – generating a steady stream
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom